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Sexually dimorphic leanness 
and hypermobility in p16Ink4a/
CDKN2A-deficient mice coincides 
with phenotypic changes in the 
cerebellum
Kwang H. Kim1, Yejin cho1, Jaehoon Lee2, Haengdueng Jeong1, Yura Lee1, Soo in Kim3,  
Chang-Hoon Kim3, Han-Woong Lee2 & Ki taek nam  1
p16Ink4a/CDKN2A is a tumor suppressor that critically regulates the cell cycle. Indeed, p16Ink4a deficiency 
promotes tumor formation in various tissues. We now report that p16Ink4a deficiency in female mice, but 
not male mice, induces leanness especially in old age, as indicated by lower body weight and smaller 
white adipose tissue, although other major organs are unaffected. Unexpectedly, the integrity, number, 
and sizes of adipocytes in white adipose tissue were unaffected, as was macrophage infiltration. 
Hence, hypermobility appeared to be accountable for the phenotype, since food consumption was 
not altered. Histological analysis of the cerebellum and deep cerebellar nuclei, a vital sensorimotor 
control center, revealed increased proliferation of neuronal cells and improved cerebellum integrity. 
expression of estrogen receptor β (eRβ) and PCNA also increased in deep cerebellar nuclei, implying 
crosstalk between p16Ink4a and eRβ. Furthermore, p16Ink4a deficiency expands LC3B+ cells and GFAP+ 
astrocytes in response to estrogen. collectively, the data suggest that loss of p16INK4a induces sexually 
dimorphic leanness in female mice, which appears to be due to protection against cerebellar senescence 
by promoting neuronal proliferation and homeostasis via eRβ.
Appropriate control of stem/progenitor cell proliferation is essential to maintain tissue homeostasis in multicel-
lular organisms1 and prevent tumor formation. On the other hand, loss of stem/progenitor cell proliferation is 
implicated in aging and senescence. Although recent medical advances have remarkably extended human life 
span, there are still challenges to address, including age-associated degenerative diseases like atherosclerosis2, 
diabetes3, macular degeneration4, osteoporosis5, and neurodegenerative diseases such as Parkinson’s disease6 and 
Alzheimer’s disease7, both of which are barely reversible.
p16Ink4a/CDKN2A regulates the cell cycle by slowing the progression from G1 to S phase8. For example, 
p16Ink4a binds cyclin-dependent kinase 4/69 to induce retinoblastoma-dependent cell-cycle arrest and prevent 
tumor progression. p16Ink4a is expressed at low levels in normal cells, but is induced by tumorigenic stimuli, and 
is progressively accumulated with age10,11, correlating with reduced proliferative capacity in various tissues12–14. 
These findings imply that cellular senescence due to p16Ink4a is closely linked to decreased proliferation of stem/
progenitor cells. On the other hand, ablation of p16Ink4a induces spontaneous tumorigenesis in mice and increases 
sensitivity to carcinogens15,16. Indeed, p16Ink4a is one of the most frequently inactivated genes in human cancers 
along with p5317,18. Hence, p16Ink4a appears to be a key regulator of tissue homeostasis.
Sexual dimorphism is the systemic difference in phenotype between males and females19. Accordingly, the 
effects of modifying a sexually dimorphic gene may appear predominantly in only one sex. For example, estrogen, 
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a steroid hormone and the major female sex hormone, is essential for the development and regulation of the 
female reproduction system. However, estrogen also affects numerous cell processes20,21, including neuronal 
development, as has been documented for years22. Many of these effects are mediated by estrogen receptor α 
(ERα) and estrogen receptor β (ERβ), which are also regulators of neuronal processes such as Purkinje cell dif-
ferentiation and expression of neurotrophin brain-derived neurotrophic factor23,24. Indeed, ERβ knockout mice 
exhibit impaired spatial learning, neuronal migration, and increased apoptosis25. Importantly, estrogen therapy 
initiated at onset of menopause reduces the risk or delays the onset of Alzheimer’s disease in women26,27, suggest-
ing a protective role against neurodegeneration.
We now report that p16Ink4a-deficient female mice gain less weight and accumulate smaller white adipose 
tissue, effects that became more pronounced with age. These effects are absent from male mice, indicating sexual 
dimorphism in p16Ink4a activity, probably via crosstalk with estrogen receptors. We also investigated the underly-
ing mechanisms, with a view to characterize this previously unreported function of p16Ink4a.
Results
p16Ink4a deficiency suppresses weight gain in female mice. By measuring the weight of p16Ink4a−/− 
(p16−/−) FVB mice and littermates (p16+/+) at 4–35 weeks from birth, we found that ablation of p16Ink4a sup-
presses weight gain in female but not male mice. This effect became more pronounced with age (Fig. 1A, left 
panel), and was also observed in C57BL/6 mice (Fig. 1A, right panel). In addition, spontaneous proliferating 
lesions were more frequent in 1 year-old p16−/− mice (Supplemental Table S1), as verified by a blinded patholo-
gist, and in agreement with previous reports demonstrating that p16Ink4a deletion deregulates the cell cycle and 
promotes tumorigenesis28. However, food intake was comparable between p16+/+ and p16−/− FVB mice at 8 
weeks (before weight differences were observed), 18 weeks (at the time weight differences were observed), and 52 
weeks (after body weights started to differ) (Fig. 1B), indicating that p16Ink4a deficiency does not induce anorexia 
due to tumor growth. Blood chemistry data show that p16Ink4a deficiency induces some metabolic changes in 1 
year old male but not female mice (Fig. 1C). In addition, most organs, including the brain, liver, kidney, spleen, 
lung, heart, and brown adipose tissue, were comparable in weight in 1 year-old p16+/+ and p16−/− FVB male and 
female mice, but white adipose tissues were dramatically lighter in female but not male p16−/− mice (Fig. 1D,E).
p16Ink4a depletion does not affect adipose tissue physiology. Since estrogen is a major regulator of 
adipose tissue in female animals29, we examined whether p16Ink4a depletion may affect the expression of estrogen 
receptors or the number of cells expressing estrogen receptors. Thus, paraffinized sections of white adipose tissue 
from 1 year-old p16+/+ and p16−/− FVB male and female mice were immunohistochemically stained with anti-
bodies to ERα and ERβ. While ERα-expressing cells were not detected (Fig. 2A, left), ERβ-expressing cells were 
found throughout the entire tissue section. However, the number of ERβ+ cells was comparable between p16+/+ 
and p16−/− mice of both sexes (Fig. 2A, right). F4/80+ macrophages, which infiltrate adipose tissues in obese 
organisms and are significantly and positively correlated with adipocyte size30, were also comparable in number 
between p16+/+ and p16−/− mice (Fig. 2B). In addition, adipocytes are similar in size among all animals (Fig. 2C), 
indicating that p16Ink4a deficiency does not affect adipose tissues per se.
p16Ink4a deficiency promotes neural cell proliferation in female mice. We observed that female 
p16−/− mice are hyperactive in comparison to female p16+/+ mice. Indeed, movement tracking for 3 min revealed 
that the former moved across 2-fold longer distance than the latter, suggesting that p16Ink4a deficiency may be 
linked to hypermobility in females. In contrast, mobility was comparable in male p16+/+ and p16−/− mice (Fig. 3A 
and Supplemental Fig. 1).
ERα-expressing cells were observed by immunohistochemistry in the thalamus (Supplemental Fig. 2) but not 
in the cerebellum, which coordinates motor activities31 (Fig. 3B). In contrast, ERβ-expressing cells were pervasive 
throughout the cerebellum, including in the molecular and granular layer and in deep cerebellar nuclei (Fig. 3C). 
ERβ+ cells were more abundant in female (~27 cells/high-power field in the molecular and granular layer, ~18 
cells/high-power field in deep cerebellar nuclei) than in male mice (~18 cells/high-power field in the molecular 
and granular layer, ~12 cells/high-power field in deep cerebellar nuclei), but comparable between p16+/+ and 
p16−/− male mice (Fig. 3C). However, ERβ+ cells were more abundant in female p16−/− mice. In addition, cells 
expressing proliferating cell nuclear antigen (PCNA), a marker of proliferation, were significantly more abundant 
in the same tissues in female p16−/− mice than in female p16+/+ mice at 18 and 52 weeks (Fig. 4A), even though 
comparable in number among all male mice. Similarly, cells expressing Ki67, also a marker of proliferation, accu-
mulated at all time points examined in female p16−/− mice only (Fig. 4B). Finally, double immunofluorescence 
staining indicated that ERβ+ PCNA+ cells in deep cerebellar nuclei were significantly more abundant in p16−/− 
female mice than in wild type female mice, but comparable among all male mice (Fig. 5), suggesting that sup-
pression of p16Ink4a enhances mobility in female mice, possibly via estrogen-associated neural cell proliferation.
p16Ink4a deficiency protects female cerebella from aging-associated deterioration. We inves-
tigated whether p16Ink4a deficiency may protect the cerebellum from deterioration, which is typically associated 
with age or neurodegeneration32. Loss of p16Ink4a slightly expanded the granular layer, although the size of the 
entire cerebellum was not affected (Fig. 6A). In addition, astrocytes, the major cell type that maintains brain 
integrity33, were more abundant in the deep cerebellar nuclei region of p16−/− mice, as assessed by staining for 
GFAP (Fig. 6B, white dotted line). Nevertheless, p16Ink4a deficiency did not enhance astrocyte proliferation as 
assessed by staining for PCNA (Supplemental Fig. 3).
Autophagy, which is essential for survival of neural cells and is impaired in neurodegenerative disorders and 
during senescence34,35, is more robust in p16−/− female mice than in female p16+/+ mice, as suggested by the 
accumulation of LC3B+ cells in the deep cerebellar nuclei region (~19 cells/high-power field in p16+/+, ~27 cells/
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Figure 1. p16Ink4a deficiency inhibits weight gain in female mice of different genetic backgrounds. (A,B) p16+/+ 
and p16−/− male and female mice were weighed weekly at 4 to 35 weeks while housed specific pathogen-free on 
diets of 25% protein, 13% fat, and 62% carbohydrates (A). Food intake per mouse was measured at 8, 18, and 52 
weeks (B) (n = 5). (C) Blood chemistry analysis of sera from 1 year old p16+/+ and p16−/− male and female mice 
(n = 9). (D,E) p16+/+ and p16−/− male and female mice were sacrificed at 1 year, and the brain, liver, kidney, 
spleen, lung, heart, white adipose tissue, brown adipose tissue, and total body were weighed D (n = 5–9). Mice 
were also imaged after opening the abdominal cavity (E,A,B,D) data are representative of three independent 
experiments. Results are mean ± SD.
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high-power field in p16−/−). However, autophagy was comparable among male mice (Fig. 6C). These results sug-
gest that p16Ink4a deficiency may protect the cerebellum by activating autophagy.
Discussion
We found that deletion of p16Ink4a, a cell cycle regulator, attenuates age-associated obesity in female mice by 
inducing hypermobility. Protection against deterioration of the cerebellum, a motor center, appears to be essential 
to this phenotype, since ablation of p16Ink4a promotes neuronal cell proliferation and increases autophagic cells 
and astrocytes in this region of the brain. However, p16Ink4a deficiency was not similarly beneficial in male mice, 
presumably as a result of sexual dimorphism, as seen in many different phenotypes19,36. The dimorphism is likely 
mediated by estrogen, which is essential to female development but which also regulates brain development and 
homeostasis, especially in females. Estrogen receptors are also more abundantly expressed in the female brain 
than in the male brain37, in line with our results.
In specific pathogen-free breeding, mice consume feed continuously in confined spaces with little mobility, such 
that the abdominal cavity becomes full of fat in most of these mice after a year or so. Remarkably, this phenomenon 
was not observed in p16Ink4a -deficient female mice. Hence, we hypothesized that ablation of p16Ink4a may affect 
the development of white adipose tissue or induce metabolic changes. However, we did not find differences in the 
number of adipocytes expressing estrogen receptors, the size of adipocytes, and the number of infiltrating F4/80+ 
Figure 2. p16Ink4a deficiency does not alter homeostasis in white adipose tissue. (A) White adipose tissues 
from p16+/+ and p16−/− FVB male and female mice were stained with anti-ERα (left panel) and anti-ERβ 
(right panel). ERβ+ cells (brown) were quantified at high power (n = 15). (B) Number of F4/80+ cells (brown) 
(n = 15). (C) Adipocyte size (n = 15). HPF, high power field. Results are mean ± SD.
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macrophages, which is significantly and positively correlated with both adipocyte size and body weight30. Therefore, 
ablation of p16Ink4a has little effect on adipocyte metabolism. On the other hand, senescence of the cerebellum 
reduces motility, which can also lead to obesity38,39. Remarkably, we found that suppression of p16Ink4a increases pro-
liferation of neuronal cells, delays senescence in the cerebellum, and enhances mobility. In addition, p16−/− female 
mice were also more responsive to peripheral stimulation than wild type (data not shown).
Homeostasis is critical in the brain, an organ with less proliferation but longer cell life, than in other tissues. 
GFAP+ astrocytes, which regulate neurotransmitter trafficking and recycling, ion homeostasis, energy metabolism, 
and defense against oxidative stress to maintain brain homeostasis33, were significantly more abundant in the former 
(Fig. 6B). Also, autophagy is an important process where age-related loss of autophagy accelerates the progression 
Figure 3. Mouse mobility and distribution of estrogen receptors in the cerebellum. (A) Movements of 1 year-
old p16+/+ and p16−/− FVB mice were tracked by video for 3 min in a test cage (left images) and total distances 
were calculated (right graph) (n = 8). (B,C) Cerebellum sections from p16+/+ and p16−/− FVB male and female 
mice were stained with anti-ERα (B) or anti-ERβ (C) and ERβ+ cells (brown) were quantified (n = 15). HPF, 
high power field. Results are mean ± SD.
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of neurodegenerative disease due to accumulation of toxic protein aggregates in neurons40, and LC3 was also highly 
expressed on astrocytes41. Furthermore, neural stem cells (NSCs) are required for generating neural cell, and auto-
phagy plays an important role in stemness and neurogenesis of NSCs42,43. Notably, LC3+ neurons were more abun-
dant in the deep cerebellar nuclei region of p16−/− female mice than in wild type female mice (Fig. 6C). We also 
found that ERβ+ cells and proliferating ERβ+ cells were increased in p16−/− female (Figs 3 and 5). ERβ is important 
for maintaining neural homeostasis; in fact, ERβ deficiency in adult mouse has shown increased vulnerability to 
neurodegeneration44. In addition, ERβ signaling is important for differentiation of neuronal precursors45.
Therefore, there are two possibilities for the increased LC3+ cells in p16−/− condition: (1) promoted prolifer-
ation of ERβ+ NSCs, which were highly expressed in LC3, and (2) increased ERβ+ neural progenitor cells were 
differentiated into neuronal cells, such as LC3+ astrocyte, in response to estrogen signal following the loss of 
p16Ink4a. We need to further identify the role of the stem, progenitor, or differentiated neuron cells controlled by 
p16Ink4a in response to estrogen.
As previously reported, loss of p16Ink4a clearly induces development of sporadic cancers. However, tumors 
develop only after a considerable amount of time even if p16Ink4a is mutated, so modulating p16Ink4a at an advanced 
age to prevent dementia may still prove beneficial on balance. Alternatively, neuron-specific regulation of p16Ink4a 
and enhanced estrogen signaling may help overcome various neurological diseases.
Materials and Methods
Animal models. Animal experiments were approved by the Institutional Animal Care and Use Committee 
of Yonsei University (IACUC number: 2015–0116) and were compliant with the Guide for the Care and Use of 
Laboratory Animals. FVB and C57BL/6 mice were purchased from The Jackson Laboratory, maintained in a 
specific pathogen-free barrier facility under a 12 h light cycle, and provided PicoLab® Rodent Diet 20 (LabDiet, 
St. Louis, MO USA).
Figure 4. p16Ink4a deficiency promotes proliferation of neural cells in the cerebellum of female mice only. (A,B) 
Cerebellum sections from p16+/+ and p16−/− FVB male and female mice were stained with anti-PCNA (A, 
n = 15) and anti-Ki67 (B, n = 9–15), and stained cells in the cerebellum and in deep cerebellar nuclei (brown) 
were counted in Image J as red dots in a gray background. HPF, high power field. Results are mean ± SD.
7Scientific RepoRtS |         (2019) 9:11167  | https://doi.org/10.1038/s41598-019-47676-6
www.nature.com/scientificreportswww.nature.com/scientificreports/
TALENs were designed to cleave downstream of the p16Ink4a start codon to introduce frameshift mutations 
and thus knock out the gene. Plasmids encoding left- and right-TALENs that recognize the p16Ink4a sequences 
5′-TGCATGACGTGCGGGCACTG-3′ and 5′-GTTTCGCCCAACGCCCCGAA-3′, respectively, were obtained 
from ToolGen. TALEN mRNAs were synthesized using mMESSAGE mMACHINE T7 Ultra Kit (Thermo Fisher 
Scientific, Waltham, MA USA) following the manufacturer’s instructions, and diluted in buffer containing 
0.25 mM EDTA and 10 mM Tris pH 7.4 and pretreated with diethyl pyrocarbonate. These mRNAs were injected 
at 50 ng/μL into the cytoplasm of one-cell embryos using a piezo-driven manipulator (Prime Tech, Tsuchiura, 
Japan), as previously described46. Subsequently, embryos were transferred into foster mothers to generate F0 mice, 
which were screened by PAGE-PCR as previously described47, using genomic DNA obtained from newborns. 
PCR products of candidate knockout mice were then cloned in T-Blunt PCR Cloning Vector (SolGent, Deajeon, 
South Korea), and mutations were validated by direct sequencing (Cosmogenetech, Seoul, South Korea). Mice 
with the earliest premature stop codons were selected as p16Ink4a knockout strain.
p16+/+ and p16−/− FVB or C57BL/6 mice were maintained by crossing with p16+/− × p16+/−. Four 
weeks after birth, offspring were separated from mother cage and genotyped with the following primers: 
5′-GAGGAGAGCCATCTGGAG-3′ and 5′-CCTTGCCTACCTGAATCG-3′. p16+/+ was amplified to 153 base 
pair and p16−/− was amplified to 133 bp after PCR reaction.
Antibodies. Antibodies to F4/80 (Cat no: ab6640), Ki67 (Cat no: ab16667), LC3B (Cat no: ab48394), GFAP 
(Cat no: ab7260) were obtained from Abcam. Antibodies to ERα (Cat no: sc-390244) and PCNA (Cat no: sc-56) 
were obtained from Santa Cruz Biotechnology, while anti-ERβ (Cat no: PA1-310B) was obtained from Thermo 
Fisher Scientific.
Assessment of mouse mobility. Mouse mobility was assessed according to Cho et al.48. Briefly, male 
and female p16+/+ and p16−/− FVB mice were placed in standard polypropylene rodent breeding cages with 
standard-depth wood chip bedding, and which were not covered during experiments to prevent internal satura-
tion with odorants. A video camera (HD lens 720P 30FPS Auto Widescreen) was fixed vertically about 1 m above 
the cage and linked to a Smart 3.0 video-tracking system (Harvard apparatus©, Holliston, MA USA). Mouse 
behavior was recorded and automatically tracked for 3 min.
Blood chemistry. One-year old p16+/+ and p16−/− male and female FVB mice were sacrificed using by CO2 
gas, and total blood was immediately obtained from the heart using 26G 1 ml syringe. To isolate serum form of 
total blood, blood samples were placed in the MiniCollect® tube (Greiner Bio-One, Kremsmünster, Austria) and 
centrifugation 1 × 104 rpm for 5 min at room temperature. Sera (10 μL) from 1 year-old p16+/+ and p16−/− male 
and female FVB mice were analyzed on a DRI-chem 4000i (Fuji, Minato, Japan) automated clinical chemistry 
analyzer to quantify changes in albumin (ALB), alkaline phosphatase (ALP), aspartate aminotransferase (AST), 
total cholesterol (TCHO), alanine aminotransferase (ALT), and total bilirubin (TBIL).
Figure 5. Estrogen signaling promotes the proliferation of neural cells in deep cerebellar nuclei region of 
female p16Ink4a knockout mice. Sections of deep cerebellar nuclei from p16+/+ and p16−/− FVB male and female 
mice were stained with anti-ERβ (red) and anti-PCNA (green) to quantify ERβ+ PCNA+ cells/field. Nuclei were 
stained with DAPI (blue) (n = 15–21). Results are mean ± SD.
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food intake. Each of the two mice groups were bred in a single cage, and were supplied with 200 g of PicoLab® 
Rodent Diet 20. We measured the amount of food left on a digital scale, and the amount of reduced food was defined 
as the amount of food the mice ingested. The measurement was performed every other day for two weeks, and the 
results were converted to the amount of food consumed per week. The amount of food powder that fell to the bottom 
of the cage was negligible in this measurement, since its amount had no significant effect on the result.
Figure 6. p16Ink4a regulates senescence in the cerebellum. (A) Size of the granular (GL) and molecular layer 
(ML) in the cerebellum of p16+/+ and p16−/− female FVB mice (n = 15). (B) Sections of deep cerebellar nuclei 
from p16+/+ and p16−/− female FVB mice were stained with anti-GFAP, and GFAP+ cells (brown, black arrow 
head) were quantified at high power (right panel) (n = 9). (C) Cerebellum sections from p16+/+ and p16−/− FVB 
male and female mice were stained with anti-LC3B, and LC3B+ cells (brown) were counted in ImageJ as red 
dots in a gray background (n = 15). HPF, high power field. Results are mean ± SD.
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Immunohistochemistry and immunofluorescence. For immunohistochemistry, tissues were fixed 
with ice-cold 4% paraformaldehyde in phosphate-buffered saline and mounted in paraffin blocks by conventional 
methods. Samples were sectioned at 3 μm, deparaffinized with xylene three times for every 20 min, 100% EtOH 
three times for every 10 min, 90% EtOH two times for every 10 min, and 75% EtOH for 10 min, and then rehy-
drated in PBS. Antigens were then retrieved for 15 min at high pressure in Target Retrieval Solution (Dako, Santa 
Clara, CA USA). Subsequently, specimens were chilled on ice for 1 h, washed with PBS three times for 5 min, and 
blocked with 3% H2O2 in PBS for 30 min to quench endogenous peroxidase. Slides were washed again with PBS, 
blocked for 2 h at room temperature with Serum-Free Protein Block (Dako, Santa Clara, CA USA), probed at 4 °C 
overnight with primary antibodies (1/1 000 dilution), stained for 30 min with anti-mouse (Dako, Santa Clara, 
CA USA) or anti-rabbit IgG (Dako, Santa Clara, CA USA) conjugated to horseradish peroxidase, and developed 
with Liquid DAB + Substrate Chromogen System (Dako, Santa Clara, CA USA). Finally, specimens were coun-
terstained with Mayer’s hematoxylin (Dako, Santa Clara, CA USA) and mounted with Shandon Synthetic Mount 
(Thermo Fisher Scientific, Waltham, MA USA).
For immunofluorescence, tissues samples were blocked as described, probed at 4 °C overnight with pri-
mary antibodies (1/1 000 dilution), labeled for 2 h with anti-mouse IgG conjugated to Alexa 488 (Thermo 
Fisher Scientific, Waltham, MA USA) or with anti-rabbit IgG conjugated to cyanine5 (Thermo Fisher Scientific, 
Waltham, MA USA), and stained with DAPI for 15 min. Finally, slides were mounted with ProLong™ Gold anti-
fade reagent (Thermo Fisher Scientific, Waltham, MA USA), imaged on an LSM 700 confocal microscope (Zeiss, 
Oberkochen, Germany), and analyzed using Zeiss Zen Blue Edition.
Statistical analysis. Statistical significance between the two groups was determined by unpaired nonpara-
metric Mann-Whitney test. P value < 0.05 was considered statistically significant, and significance was designated 
with asterisks (N.S., not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001). All data were evaluated 
in GraphPad Prism version 7.0d (GraphPad, San Diego, CA USA) for statistical analyses.
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